Genprex
GNPX
17 hedge funds and large institutions have $155K invested in Genprex in 2026 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
13% more funds holding
Funds holding: 15 → 17 (+2)
0.01% less ownership
Funds ownership: 0.14% → 0.12% (-0.01%)
8% less capital invested
Capital invested by funds: $169K → $155K (-$14K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
+$68.1K |
| 2 |
HF
HRT Financial
New York
|
+$62.9K |
| 3 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$26.5K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$23.5K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$18.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Manchester Financial
Westlake Village,
California
|
-$36.2K |
| 2 |
FIA
FNY Investment Advisers
New York
|
-$9K |
| 3 |
CCA
Cygnus Capital Advisors
Atlanta,
Georgia
|
-$4K |
| 4 |
Citigroup
New York
|
-$3.69K |
| 5 |
SIS
Sound Income Strategies
Ft Lauderdale,
Florida
|
-$1.58K |
GNPX Hedge Fund Activity: Q2 2026 in Review
17 of the 8,320 institutional investors tracked by Wall St. Rank reported a position in Genprex (GNPX) for Q2 2026, worth a combined $155K — down 8.3% from $169K a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new GNPX positions and 5 closed out — a net gain of 2 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Fiduciary Trust, opening a new position worth an estimated $68.1K. The largest seller was Manchester Financial, exiting entirely with an estimated $36.2K sold.
- 17 institutional investors held Genprex (GNPX) as of Q2 2026, up from 15 in Q1 2026.
- Funds reported $155K of Genprex stock for Q2 2026, down 8.3% quarter-over-quarter.
- 7 funds opened new Genprex positions in Q2 2026 and 5 closed out, a net change of +2 holders.
- The largest Genprex buyer in Q2 2026 was Vanguard Fiduciary Trust, an estimated $68.1K added.
- The largest Genprex seller in Q2 2026 was Manchester Financial, an estimated $36.2K sold.
Based on aggregated 13F filings for Q2 2026.